Zealand Pharma A/S
Zealand Pharma A/S, a leading biotechnology company headquartered in Denmark (DK), is renowned for its innovative approach to peptide-based therapeutics. Founded in 1998, the company has made significant strides in the biopharmaceutical industry, focusing on the development of novel treatments for diabetes, obesity, and gastrointestinal disorders. With a strong presence in Europe and North America, Zealand Pharma is committed to advancing its core products, which include unique peptide therapies that offer targeted solutions for complex health issues. The company has achieved notable milestones, including strategic partnerships and successful clinical trials, solidifying its position as a key player in the global biopharmaceutical market. Zealand Pharma's dedication to scientific excellence and patient-centric solutions continues to drive its growth and impact in the healthcare landscape.
DitchCarbon Score
How does Zealand Pharma A/S's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Zealand Pharma A/S's score of 25 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Zealand Pharma A/S's reported carbon emissions
As of the latest available data, Zealand Pharma A/S does not report specific carbon emissions figures. However, the company has made significant climate commitments, including a commitment to achieve net-zero emissions. This commitment is classified as "Committed" under the Science Based Targets initiative (SBTi), indicating that Zealand Pharma is actively working towards reducing its carbon footprint in alignment with global climate goals. Zealand Pharma is situated in Denmark and operates within the Pharmaceuticals, Biotechnology, and Life Sciences sector. While specific reduction targets have not been detailed, the company's commitment to net-zero emissions reflects a proactive approach to addressing climate change. It is important to note that Zealand Pharma's emissions data is not cascaded from any parent organization, ensuring that their climate commitments and strategies are independently defined. The company is focused on integrating sustainability into its operations, contributing to broader industry efforts to mitigate climate impact.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Zealand Pharma A/S is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
